Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maltofer Fol vs iron sulfate in pregnant women with iron-deficiency anaemia
2007-001517-41Phase 3Terminated
- Sponsor
- CSL Vifor
- Start
- Oct 2007
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised trial of iron polymaltose in iron deficiency anemia (IDA) (2 arms), sponsored by CSL Vifor. Primary endpoint: Change in haemoglobin from baseline to Day 90. Started Oct 2007; status: terminated.
02
Drugs
iron polymaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on 2007-001517-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001517-41.